Worldwide Opioid Induced Constipation Drugs Industry to 2030 - North America Currently Leads the Market
20 sept. 2022 06h08 HE
|
Research and Markets
Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "Opioid Induced Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
Insights on the Irritable Bowel Syndrome with Constipation Drugs Global Market to 2030 - Increasing Consumption of Spicy Food Will Spur the Market in the Asia-Pacific Region
09 sept. 2022 05h58 HE
|
Research and Markets
Dublin, Sept. 09, 2022 (GLOBE NEWSWIRE) -- The "Irritable Bowel Syndrome with Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players,...
Worldwide Chronic Idiopathic Constipation (CIC) Drugs Industry to 2030 - by Drug Type, Prescription Type and Region
07 sept. 2022 05h43 HE
|
Research and Markets
Dublin, Sept. 07, 2022 (GLOBE NEWSWIRE) -- The "Chronic Idiopathic Constipation (CIC) Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
Global Irritable Bowel Syndrome (IBS) Market Outlook Report 2022-2028: Rising Commercialization of Existing Products in Several Regions is Predicted to Accelerate Growth
01 mars 2022 07h43 HE
|
Research and Markets
Dublin, March 01, 2022 (GLOBE NEWSWIRE) -- The "Global Irritable Bowel Syndrome Market Outlook: Opportunity And Demand Analysis, Market Forecast, 2019-2028" report has been added to...
Worldwide Irritable Bowel Syndrome Treatment Industry to 2028 - Increasing Disposable Incomes Presents Opportunities
12 juil. 2021 05h23 HE
|
Research and Markets
Dublin, July 12, 2021 (GLOBE NEWSWIRE) -- The "Irritable Bowel Syndrome Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type [IBS with Diarrhea, IBS with Constipation, and...
Worldwide Irritable Bowel Syndrome with Constipation Drugs Industry to 2028 - Rising Prevalence of Gastrointestinal Disorders Will Significantly Increase the Demand
26 févr. 2021 06h18 HE
|
Research and Markets
Dublin, Feb. 26, 2021 (GLOBE NEWSWIRE) -- The "Irritable Bowel Syndrome with Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players,...
Insights on the Opiod Induced Constipation Drugs Global Market to 2028 - by Drug Type, Prescription Type and Geography
22 févr. 2021 07h18 HE
|
Research and Markets
Dublin, Feb. 22, 2021 (GLOBE NEWSWIRE) -- The "Opiod Induced Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
China Food and Drug Administration Accepts IND for Pivotal Study of AMITIZA(R) (lubiprostone)
15 juin 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., June 15, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global pharmaceutical company, today announced that the China Food and Drug Administration...
Sucampo Announces Acceptance of New Drug Submission for AMITIZA(R) (lubiprostone) by Health Canada
30 déc. 2014 17h00 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Dec. 30, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Health Canada has accepted the...
Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)
21 oct. 2014 18h00 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., October 21, 2014 and OSAKA, Japan, October 22, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, and Takeda...